Unmasking Intra-Tumoral Heterogeneity and Clonal Evolution in NF1-MPNST
Authors:
- Chang-In MoonCMChang-In Moon
- William TompkinsWTWilliam Tompkins
- Yuxi WangYWYuxi Wang
- Abigail GodecAGAbigail Godec
- Xiaochun ZhangXZXiaochun Zhang
- Patrik PipkornPPPatrik Pipkorn
- Christopher A. MillerCMChristopher A. Miller
- Carina DehnerCDCarina Dehner
- Sonika DahiyaSDSonika Dahiya
- Angela C. HirbeAngela C. Hirbe
Open Access
Abstract
Sarcomas are highly aggressive cancers that have a high propensity for metastasis, fail to respond to conventional therapies, and carry a poor 5-year survival rate. This is particularly true for patients with neurofibromatosis type 1 (NF1), in which 8%–13% of affected individuals will develop a malignant peripheral nerve sheath tumor (MPNST). Despite continued research, no effective therapies have emerged from recent clinical trials based on preclinical work. One explanation for these failures could be the lack of attention to intra-tumoral heterogeneity. Prior studies have relied on a single sample from these tumors, which may not be representative of all subclones present within the tumor. In the current study, samples were taken from three distinct areas within a single tumor from a patient with an NF1-MPNST. Whole exome sequencing, RNA sequencing, and copy number analysis were performed on each sample. A blood sample was obtained as a germline DNA control. Distinct mutational signatures were identified in different areas of the tumor as well as significant differences in gene expression among the spatially distinct areas, leading to an understanding of the clonal evolution within this patient. These data suggest that multi-regional sampling may be important for driver gene identification and biomarker development in the future.Keywords
Funding Information
- Neurofibromatosis Therapy Acceleration Program (3070-37791)
This publication has 118 references indexed in Scilit:
- Loss of ASAP3 destabilizes cytoskeletal protein ACTG1 to suppress cancer cell migrationMolecular Medicine Reports, 2013
- Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney TumorCell, 2012
- VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencingGenome Research, 2012
- First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group studyAnnals of Oncology, 2010
- PTEN dosage is essential for neurofibroma development and malignant transformationProceedings of the National Academy of Sciences, 2009
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short readsBioinformatics, 2009
- Coding-Sequence Determinants of Gene Expression in Escherichia coliScience, 2009
- An expectation-maximization algorithm for probabilistic reconstructions of full-length isoforms from splice graphsNucleic Acids Research, 2006
- The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteBritish Journal of Cancer, 2004